This Week Last Year in Medtech: Oct. 16-22

Some of Abbott’s Alinity Tests Face Class I Recall

The recall was issued because of the potential for false-positive results due to the software associated with the tests.

5 More Private Medtech Companies That Are Killing It This Year

These private medtech companies are worth keeping tabs on, according to industry analysts.

Globus Medical Is Firing on All Cylinders with Its Spine Robotics Platform (and Investors Are Noticing)

A medtech analyst shares insights for one of his most frequently asked about companies.

RFID for Medical Consumables: Closing the Loop Between Patients, Providers, & Product

Medical device manufacturers have an opportunity to reduce medical errors and streamline workflows through RFID use.

What’s the State of Medtech in 2021?

The COVID-19 pandemic boosted demand for some medical device sectors, but 5 key trends may be key for ongoing growth.

Abbott CEO Shares Most Important Lessons Learned During the COVID-19 Pandemic

The company’s Q3 results were phenomenal – but these takeaways will benefit us all.

Conmed Is Showing Growth Potential

Conmed shares have pulled back somewhat recently, but analysts note the company's potential for increasing revenue growth.